These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. A Drosophila model of the neurological symptoms in Mpv17-related diseases. Kodani A; Yamaguchi M; Itoh R; Huynh MA; Yoshida H Sci Rep; 2022 Dec; 12(1):22632. PubMed ID: 36587049 [TBL] [Abstract][Full Text] [Related]
44. Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series. Mahjoub G; Habibzadeh P; Dastsooz H; Mirzaei M; Kavosi A; Jamali L; Javanmardi H; Katibeh P; Faghihi MA; Dastgheib SA BMC Med Genet; 2019 Oct; 20(1):167. PubMed ID: 31664948 [TBL] [Abstract][Full Text] [Related]
45. Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome? Vu TH; Tanji K; Holve SA; Bonilla E; Sokol RJ; Snyder RD; Fiore S; Deutsch GH; Dimauro S; De Vivo D Hepatology; 2001 Jul; 34(1):116-20. PubMed ID: 11431741 [TBL] [Abstract][Full Text] [Related]
51. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246 [TBL] [Abstract][Full Text] [Related]
52. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults. Ouvrier R; Grew S Dev Med Child Neurol; 2010 Apr; 52(4):328-30. PubMed ID: 20163430 [TBL] [Abstract][Full Text] [Related]
54. Peripheral neuropathy in genetically characterized patients with mitochondrial disorders: A study from south India. Bindu PS; Govindaraju C; Sonam K; Nagappa M; Chiplunkar S; Kumar R; Gayathri N; Bharath MM; Arvinda HR; Sinha S; Khan NA; Govindaraj P; Nunia V; Paramasivam A; Thangaraj K; Taly AB Mitochondrion; 2016 Mar; 27():1-5. PubMed ID: 26762927 [TBL] [Abstract][Full Text] [Related]
55. The role of the Mpv17 protein mutations of which cause mitochondrial DNA depletion syndrome (MDDS): lessons from homologs in different species. Löllgen S; Weiher H Biol Chem; 2015 Jan; 396(1):13-25. PubMed ID: 25205723 [TBL] [Abstract][Full Text] [Related]
56. Neurophysiological profile of peripheral neuropathy associated with childhood mitochondrial disease. Menezes MP; Rahman S; Bhattacharya K; Clark D; Christodoulou J; Ellaway C; Farrar M; Pitt M; Sampaio H; Ware TL; Wedatilake Y; Thorburn DR; Ryan MM; Ouvrier R Mitochondrion; 2016 Sep; 30():162-7. PubMed ID: 27475922 [TBL] [Abstract][Full Text] [Related]
57. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies. Li J; Ghandour K; Radovanovic D; Shy RR; Krajewski KM; Shy ME; Nicholson GA Arch Neurol; 2007 Jul; 64(7):974-8. PubMed ID: 17620487 [TBL] [Abstract][Full Text] [Related]
58. Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex. Gilberti M; Baruffini E; Donnini C; Dallabona C PLoS One; 2018; 13(10):e0205014. PubMed ID: 30273399 [TBL] [Abstract][Full Text] [Related]
59. MPV17 does not control cancer cell proliferation. Canonne M; Wanet A; Nguyen TTA; Khelfi A; Ayama-Canden S; Van Steenbrugge M; Fattaccioli A; Sokal E; Najimi M; Arnould T; Renard P PLoS One; 2020; 15(3):e0229834. PubMed ID: 32155188 [TBL] [Abstract][Full Text] [Related]